Nachrichten zur TETRA Technologies Aktie

Theratechnologies Reports on its Annual Meeting of Shareholders

MONTREAL, May 09, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a…

Theratechnologies to Present Long-Term Efficacy, Safety and Pharmacokinetic Data on Use of TH1902 (sudocetaxel zendusortide) in Solid Tumors at 2024 ASCO Meeting

MONTREAL, May 02, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a…

TETRA Technologies, Inc. (TTI) Q1 2024 Earnings Call Transcript

…

Theratechnologies Inc. (THTX) Q1 2024 Earnings Call Transcript

…

Theratechnologies Reports Financial Results and Provides Business Update for First Quarter 2024

MONTREAL, April 10, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a…

Theratechnologies Appoints Elina Tea to its Board of Directors

MONTREAL, April 05, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a…

Theratechnologies to Announce First Quarter 2024 Financial Results and Provide Business Update

MONTREAL, April 03, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a…

Theratechnologies to Present Preclinical Data at AACR on Multiple PDCs Showcasing Potential of SORT1+Technology™ Platform

MONTREAL, March 28, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a…

Theratechnologies Appoints Jordan Zwick to its Board of Directors

MONTREAL, March 21, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a…

TETRA Technologies appoints ex-BP veteran as new board member By Investing.com

TETRA Technologies appoints ex-BP veteran as new board member…

Tetra Technologies reports Q4 results

…

Theratechnologies Announces the Resignation of One of Its Directors, Mr. Alain Trudeau

MONTREAL, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a…

TETRA Technologies, Inc. (TTI) Q4 2023 Earnings Call Transcript

…

Theratechnologies Inc. (THTX) Q4 2023 Earnings Call Transcript

…

Theratechnologies Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2023 and Provides 2024 Guidance

MONTREAL, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a…

Theratechnologies Announces Publication in Frontiers in Immunology that Deepens Understanding of Sudocetaxel Zendusortide (TH1902) Molecular Mechanism of Action

MONTREAL, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a…

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Theratechnologies Inc. - THTX

NEW YORK, Feb. 11, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of…

Surface Well Testing Market Size - Global Forecasts to 2029

Baker Hughes, Expro, Halliburton, Roska DBO, Schlumberger, Tetra Technologies, Weatherford International, National Oilwell Varco, Worldwide Oilfield Machine, Sayatva, Hamdon Energy…

Theratechnologies to Announce Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update

MONTREAL, Feb. 06, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a…

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Theratechnologies Inc. - THTX

NEW YORK, Feb. 03, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of…

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Theratechnologies Inc. - THTX

NEW YORK, Jan. 26, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of…

Theratechnologies Receives Complete Response Letter (CRL) from the FDA for the F8 Formulation of Tesamorelin sBLA

MONTREAL, Jan. 24, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a…

Theratechnologies Submits sBLA for Trogarzo® Intramuscular (IM) Method of Administration to FDA

MONTREAL, Jan. 02, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a…

Theratechnologies Announces FDA Approval of Trogarzo® 90-Second Intravenous (IV) Push Loading Dose

MONTREAL, Dec. 13, 2023 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a…

TETRA Technologies: Highlighting Potential Lithium Royalty

…

TETRA Technologies, Inc. (TTI) Q3 2023 Earnings Call Transcript

…

Theratechnologies Announces Closing of US$25 Million Public Offering of Common Shares and Concurrent Private Placement

MONTREAL, Oct. 31, 2023 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (Nasdaq: THTX; TSX: TH), a…

Tetra Technologies (TTI) Lags Q3 Earnings and Revenue Estimates

Tetra Technologies (TTI) delivered earnings and revenue surprises of -12.50% and 7.70%, respectively, for the quarter ended September 2023. Do…

Theratechnologies’ Ibalizumab Demonstrates Cost-Effectiveness as an Addition to Routine Clinical Care in Heavily Treatment-Experienced People with HIV

MONTREAL, Oct. 19, 2023 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a…

Theratechnologies Announces Dosing of First Patient in Updated Clinical Trial of Sudocetaxel Zendusortide in Advanced Ovarian Cancer

MONTREAL, Oct. 12, 2023 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a…

Onshore Drilling Fluid Market to Hit US$ 6,660.67 Million By 2031 | Updated Insights

Consegic Business Intelligence analyzes that the onshore drilling fluid market is growing with a CAGR of 5.1% during the forecast…

Theratechnologies Reports Financial Results for the Third Quarter and Nine Months of Fiscal 2023 and Provides Business Updates

MONTREAL, Sept. 26, 2023 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a…

Theratechnologies Submits Tesamorelin F8 Formulation sBLA for FDA Review

MONTREAL, Sept. 25, 2023 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a…

Theratechnologies to Present at the Cantor Fitzgerald Global Healthcare Conference 2023

MONTREAL, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a…

Theratechnologies to Announce Third Quarter 2023 Financial Results and Provide Business Update

MONTREAL, Sept. 18, 2023 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a…

Can Tetra Technologies (TTI) Run Higher on Rising Earnings Estimates?

Tetra Technologies (TTI) shares have started gaining and might continue moving higher in the near term, as indicated by solid…

What Makes Tetra Technologies (TTI) a Strong Momentum Stock: Buy Now?

Does Tetra Technologies (TTI) have what it takes to be a top stock pick for momentum investors? Lets find out....…

Form 8-K TETRA TECHNOLOGIES INC For: Aug 01

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Tetra Technologies (TTI) Q2 Earnings and Revenues Beat Estimates

Tetra Technologies (TTI) delivered earnings and revenue surprises of 62.50% and 3.89%, respectively, for the quarter ended June 2023. Do…

Tetra Technologies Non-GAAP EPS of $0.13 beats by $0.04, revenue of $175.46M beats by $2.93M

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 10-Q TETRA TECHNOLOGIES INC For: Jun 30

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

TETRA TECHNOLOGIES, INC. ANNOUNCES STRONG SECOND QUARTER 2023 RESULTS WITH REVENUE OF $175.5 MILLION, GAAP EPS OF $0.14, GAAP NET INCOME OF $18.2 MILLION AND ADJUSTED EBITDA OF $36.0 MILLION

Second quarter revenue is a record high for the Company, excluding discontinued operations, and increased 25% year-over-year. Net income improved…

dpa-AFX ProFeed